Found 6 matching trials
IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting
PHASE2Following myocardial infarct, cellular therapy is a potential approach to r...
Location
Peter Munk Cardiac Center/ University Health Network
Bone Marrow Derived AC 133+ and Mono-Nuclear Cells (MNC) Implantation in Myocardial Infarction (MI) Patient
PHASE2Although a percutaneous coronary intervention (PCI) can be used to open up ...
Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty
PHASE1The main aim of the present study was to evaluate the therapeutic potential...
Location
Shanghai Tenth People's Hospital, Tong ji University
Autologous Bone Marrow Derived Stem Cells for Acute Myocardial Infarction
PHASE3One of the important reasons for human dying is Ischemic heart disease (IHD...
Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions
PHASE1This phase I clinical trial will evaluate the safety and efficacy of intra-...
Location
Case Western Reserve University
Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas
NAStudies have provided evidence that residual microscopic malignant cells in...
Location
St. Jude Children's Research Hospital